Dataset Information


Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.

ABSTRACT: The requirement for bone-marrow aspirates for genomic profiling of multiple myeloma poses an obstacle to enrolment and retention of patients in clinical trials. We evaluated whether circulating cell-free DNA (cfDNA) analysis is comparable to molecular profiling of myeloma using bone-marrow tumour cells. We report here a hybrid-capture-based Liquid Biopsy Sequencing (LB-Seq) method used to sequence all protein-coding exons of KRAS, NRAS, BRAF, EGFR and PIK3CA in 64 cfDNA specimens from 53 myeloma patients to >20,000 × median coverage. This method includes a variant filtering algorithm that enables detection of tumour-derived fragments present in cfDNA at allele frequencies as low as 0.25% (median 3.2%, range 0.25-46%). Using LB-Seq analysis of 48 cfDNA specimens with matched bone-marrow data, we detect 49/51 likely somatic mutations, with subclonal hierarchies reflecting tumour profiling (96% concordance), and four additional mutations likely missed by bone-marrow testing (>98% specificity). Overall, LB-Seq is a high fidelity adjunct to genetic profiling of bone-marrow in multiple myeloma.

PROVIDER: S-EPMC5437268 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| E-GEOD-4581 | BioStudies
| S-EPMC6778199 | BioStudies
| S-EPMC3261674 | BioStudies
| S-EPMC3578800 | BioStudies
2008-06-13 | E-GEOD-4581 | ArrayExpress
| S-EPMC6442234 | BioStudies
| S-EPMC4022385 | BioStudies
2011-12-06 | BIOMD0000000401 | BioModels
2011-11-25 | BIOMD0000000402 | BioModels
| E-MTAB-9139 | BioStudies